Current Illinois CancerCare Clinical Trials

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Study Number: A031702

Status: Open

Just In Time Trial

Study available for the following diagnoses:
Small cell carcinoma of the bladder
Plamacytoid urothelial carcinoma
Penile
Sarcomatoid renal cell carcinoma
Sarcomatoid urothelial carcinoma
Renal medullary carcinoma
Miscellaneous histologic variants of urothelial carcinoma

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621 cgeoffroy@illinoiscancercare.com
  • Alyssa, 309-243-3626, awagner@illinoiscancercare.com

Study Link

« Search Again